Merck KGaA : to Invest EUR59 Million to Expand Pharmaceutical Manufacturing at US Facility

Merck KGaA : to Invest EUR59 Million to Expand Pharmaceutical Manufacturing at US Facility

Source: 
Market Screener
snippet: 

Merck KGaA said Wednesday that it would invest 59 million euros ($69.5 million) in expanding its manufacturing capabilities, and capacity for high-potent active pharmaceutical ingredients and antibody-drug conjugates at its U.S. facility near Madison, Wisc.